Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...

The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from ...

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

Moderna has withdrawn the Biologics License Application (BLA) for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after ...

Pigs could play a key role in ending the flu as we know it. That’s the message behind new research testing a ...

Estimated influenza vaccine effectiveness (VE) in California during the 2023-24 respiratory virus season was 41% against ...

University of Pennsylvania researchers have discovered a right-handed, antiparallel double-helix inside influenza ...

The Trump administration has launched a $500 million project to develop a universal flu vaccine that won't need yearly updates. But vaccine experts are mystified by its focus on a dated technology.

A new combination vaccine could simplify protection against two major respiratory illnesses for older adults, according to a ...

Moderna has withdrawn its pending application for a combination vaccine for both the flu and Covid-19, saying it will resubmit later this year once it has more data.